NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/10/2023
Back to search
Official data from USPTO
LUPIN NEUROSCIENCES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
11/10/2023
Classification
Registered
Trademark type
Combined
Nice classes
5, 44
Filing date
02/11/2020
Registration date
01/11/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/11/2022
Last transaction
01/11/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
GB
Examiner
GARDNER, DAWNA BERYL
Law office
O30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "LUPIN" above the stylized wording "NEUROSCIENCES". To the left of the wording is a thin vertical line. To the left of the line is the design of a partial silhouette of the side of a face. To the left side of the face is a six-petal flower on the top left.
Holders and representatives
Holders
Lupin Healthcare (UK) Limited
Representatives
Robert L. Powley Powley & Gibson, P.C.
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicinal and pharmaceutical preparations and substances for the treatment of degenerative and neurological diseases; medicinal and pharmaceutical preparations and substances for the treatment of central nervous system disorders and for use in treatment of disorders of the endocrinecardiovascularrenalskeletalimmune and metabolic systems
Class 44
Medical evaluation of degenerative and neurological diseasescentral nervous system disordersdisorders of the endocrinecardiovascularrenalskeletalimmune and metabolic systems; medical diagnosis of degenerative and neurological diseasescentral nervous system disordersdisorders of the endocrinecardiovascularrenalskeletalimmune and metabolic systems; medical services for the treatment of degenerative and neurological diseasescentral nervous system disordersdisorders of the endocrinecardiovascularrenalskeletalimmune and metabolic systems and physical rehabilitation; provision of medical information; providing information relating to diagnosticphophylactic and therapeutic properties of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
38 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/18/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/23/2022
FIMP
FINAL DISPOSITION PROCESSED
06/22/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/11/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
01/11/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/19/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/01/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/01/2021
GPNX
NOTIFICATION PROCESSED BY IB
11/04/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/26/2021
PUBO
PUBLISHED FOR OPPOSITION
10/26/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/06/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/06/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/19/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/08/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/08/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/23/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/12/2021
GNRT
NON-FINAL ACTION E-MAILED
03/12/2021
CNRT
NON-FINAL ACTION WRITTEN
03/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/11/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/10/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/10/2021
RFNT
REFUSAL PROCESSED BY IB
10/03/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/12/2020
RFRR
REFUSAL PROCESSED BY MPU
09/12/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/15/2020
CNRT
NON-FINAL ACTION WRITTEN
08/14/2020
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
08/13/2020
MAFR
APPLICATION FILING RECEIPT MAILED
06/30/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/28/2020
CNRT
NON-FINAL ACTION WRITTEN
06/27/2020
DOCK
ASSIGNED TO EXAMINER
06/26/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/26/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/25/2020
Continuous trademark protection
Get notified about every new filing that threatens LUPIN NEUROSCIENCES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.